Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Vulvar Neoplasms 2Melanoma 2Liver Metastases 2Ulcer 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Pathologic Processes 1Pancreatic Neoplasms 1Neoplastic Processes 1Neoplasms 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Liver Neoplasms 1Head and Neck Neoplasms 1Gynecological Cancers 1Desmoid Tumors 1Colorectal Neoplasms 1Breast Cancer Female 1

Interventions

pembrolizumab 157Gemcitabine 140Capecitabine 123Paclitaxel 121Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Docetaxel 98Leucovorin 97Cisplatin 90Radiosurgery 88Irinotecan 88Carboplatin 86Cyclophosphamide 72Cetuximab 72Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Electrochemotherapy × Clear all
NCT00918593 2011-09-27

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Copenhagen University Hospital at Herlev

Phase 2 Withdrawn
98 enrolled

Neoplasm Metastasis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡